
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
Khaoula Errafii, Neyla S. Al-Akl, Olfa Khalifa, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Khaoula Errafii, Neyla S. Al-Akl, Olfa Khalifa, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay
Pharmacological Research (2022) Vol. 185, pp. 106507-106507
Closed Access | Times Cited: 59
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay
Pharmacological Research (2022) Vol. 185, pp. 106507-106507
Closed Access | Times Cited: 59
Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
Olfa Khalifa, Neyla S. Al-Akl, Khaoula Errafii, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Olfa Khalifa, Neyla S. Al-Akl, Khaoula Errafii, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4651-4651
Open Access | Times Cited: 30
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4651-4651
Open Access | Times Cited: 30
Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells
Olfa Khalifa, Sama Ayoub, Abdelilah Arredouani
Biomedicines (2025) Vol. 13, Iss. 2, pp. 370-370
Open Access
Olfa Khalifa, Sama Ayoub, Abdelilah Arredouani
Biomedicines (2025) Vol. 13, Iss. 2, pp. 370-370
Open Access
Gehua Jiejiu Dizhi decoction ameliorates alcoholic fatty liver in mice by regulating lipid and bile acid metabolism and with exertion of antioxidant stress based on 4DLabel-free quantitative proteomic study.
Min Han, Y I Xu, You Shaowei, et al.
PubMed (2024) Vol. 44, Iss. 2, pp. 277-288
Closed Access | Times Cited: 2
Min Han, Y I Xu, You Shaowei, et al.
PubMed (2024) Vol. 44, Iss. 2, pp. 277-288
Closed Access | Times Cited: 2
Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism
Khaoula Errafii, Olfa Khalifa, Neyla S. Al-Akl, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 11
Khaoula Errafii, Olfa Khalifa, Neyla S. Al-Akl, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1020-1020
Open Access | Times Cited: 11
Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy
Olfa Khalifa, Kamal H. Mroué, Raghvendra Mall, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2652-2652
Open Access | Times Cited: 8
Olfa Khalifa, Kamal H. Mroué, Raghvendra Mall, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2652-2652
Open Access | Times Cited: 8
Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models
María Pelechá, Estela Villanueva-Bádenas, Enrique Timor-López, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 86-86
Open Access | Times Cited: 10
María Pelechá, Estela Villanueva-Bádenas, Enrique Timor-López, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 86-86
Open Access | Times Cited: 10
Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs
Shereen Ahmed El Sobky, Nourhan K. Aboud, Nihal Moustafa El assaly, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Shereen Ahmed El Sobky, Nourhan K. Aboud, Nihal Moustafa El assaly, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Targeting Long Non-Coding RNA H19 as a Therapeutic Strategy for Liver Disease.
Yulan Shi, F. Qu, Shiyun Zeng, et al.
Progress in Biophysics and Molecular Biology (2024)
Closed Access
Yulan Shi, F. Qu, Shiyun Zeng, et al.
Progress in Biophysics and Molecular Biology (2024)
Closed Access